Magnetar Financial’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-11,739
Closed -$199K – 1505
2026
Q2
$199K Sell
11,739
-55,887
-83% -$893K ﹤0.01% 942
2026
Q1
$1M Buy
67,626
+52,141
+337% +$762K 0.01% 477
2025
Q4
$247K Sell
15,485
-462
-3% -$6.55K ﹤0.01% 748
2025
Q3
$176K Buy
+15,947
New +$174K ﹤0.01% 788

Other funds holding AUPH

Magnetar Financial's AUPH Position: Q3 2026 in Review

Magnetar Financial sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2026, closing a stake of 11,739 shares — an estimated $199K sold.

Magnetar Financial first reported a position in AUPH in Q3 2025 and held it in 4 quarters. The position peaked at $1M in Q1 2026. 277 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.

  • Magnetar Financial reported no remaining Aurinia Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Magnetar Financial sold 11,739 Aurinia Pharmaceuticals shares in Q3 2026, an estimated $199K.
  • Magnetar Financial first reported a position in Aurinia Pharmaceuticals in Q3 2025 and held it in 4 quarters.
  • Magnetar Financial's Aurinia Pharmaceuticals position peaked at $1M in Q1 2026.
  • 277 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.

Based on Magnetar Financial's 13F filing for Q3 2026, filed 13 Nov 2026.